EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Management of infections caused by carbapenemase-producing Enterobacterales in France: a real-world study

B Pilmis, L Escaut, M Seguret, L Weber, F Bussy, S Figueiredo, L Dortet iD

JAC-Antimicrobial Resistance · 07.01.2026 · 8 (1)

DOI: 10.1093/jacamr/dlaf260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 09.01.2026. Verfasst von B Pilmis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Saint-Joseph & Marie-Lannelongue Hospitals, Paris, France. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Carbapenemase-producing Enterobacterales (CPE) are a significant public health concern, with limited treatment options and high mortality rates. The epidemiology and management of CPE infections in France remain insufficiently documented.

Objectives

To provide a multicentre snapshot of the management of CPE infections in France, assess current clinical practices and evaluate their alignment with international guidelines.

Methods

We conducted a multicenter, observational, cross-sectional study across 31 French hospitals between September 2021 and March 2023. Adult patients with confirmed CPE infections were included. Clinical and microbiological data were collected retrospectively. Treatment regimens were analysed, and therapeutic appropriateness was assessed based on European and international guidelines.

Results

Among 6936 screened patients, 96 met the inclusion criteria. The most frequently isolated pathogens were Klebsiella pneumoniae (42%), Escherichia coli (18%) and Enterobacter cloacae complex (16%). OXA-48-like carbapenemases were predominant (50%), followed by New Delhi metallo-β-lactamase (NDM) (38%). Initial empirical therapy was administered in 92.7% of patients overall; appropriateness was 50% in OXA-48-like infections and 25.5% in NDM infections. On multivariable analysis, 30-day mortality (34%) was associated with comorbidity burden and septic shock, whereas neither time to appropriate therapy nor therapy appropriateness independently predicted death. These data suggest outcomes were mainly driven by patient factors and severity, despite low empirical appropriateness—particularly for NDM—which supports efforts to improve early targeting through rapid diagnostics.

Conclusions

This study highlights the challenges associated with CPE infections, including high mortality and frequent inappropriate empirical therapy. Our findings emphasize the need for optimized antimicrobial stewardship and rapid microbiological diagnostics to improve patient outcomes.

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Saint-Joseph & Marie-Lannelongue Hospitals, Paris, France.
  • Micalis Institute UMR 1319, Université Paris-Saclay, INRAe, AgroParisTech, Orsay, France.
  • Faculty of Medicine, Team 'Resist' UMR1184 'Immunology of Viral, Auto-Immune, Hematological, and Bacterial Diseases (IMVA-HB),' INSERM, Université Paris-Saclay, CEA, Le Kremlin-Bicêtre, France.
  • Department of Infectious and Tropical Diseases, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, Paris-Saclay University, Le Kremlin-Bicêtre, France.
  • Department of Anesthesia and Surgical Intensive Care, Bicêtre Hospital, Paris-Saclay University, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Department of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Faculty of Medicine and Paris-Sud University, le Kremlin-Bicêtre, France.

ORCID-Profile: L Dortet

Zitieren

APA

Pilmis, B., Escaut, L., Seguret, M., Weber, L., Bussy, F., Figueiredo, S., & Dortet, L. (2026). Management of infections caused by carbapenemase-producing Enterobacterales in France: a real-world study. JAC-Antimicrobial Resistance, 8(1). https://doi.org/10.1093/jacamr/dlaf260

Vancouver

Pilmis B, Escaut L, Seguret M, Weber L, Bussy F, Figueiredo S, et al. Management of infections caused by carbapenemase-producing Enterobacterales in France: a real-world study. JAC-Antimicrobial Resistance. 2026;8(1). doi:10.1093/jacamr/dlaf260

BibTeX
@article{Pilmis2026,
  author = {Pilmis, B and Escaut, L and Seguret, M and Weber, L and Bussy, F and Figueiredo, S and Dortet, L},
  title = {Management of infections caused by carbapenemase-producing Enterobacterales in France: a real-world study},
  journal = {JAC-Antimicrobial Resistance},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/jacamr/dlaf260}
}
Kostenlos starten →